Nice thread:
NOX - going to clinic early 2017 - testing in late stage cancer patients a most potent derivative of the isoflavone family - via a novel delivery method. Looking to sensitise tumours to chemo in these terminal patients. Fantastic stuff.
PNV - still digging on this one, hoping to be fully knowledgeable before earnings from US operations hit market.
- Forums
- Commodities
- Biotech 2017
Biotech 2017, page-11
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)